NANJING CELLNUO BIOPHARMACEUTICAL CO LTD

Overview

NANJING CELLNUO BIOPHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 6 active FDA Type II Drug Master Files, covering INSULIN ASPART; RETATRUTIDE; SEMAGLUTIDE INTERMEDIATE P29; SEMAGLUTIDE, NON-STERILE DRUG SUBSTANCE; TIRZEPATIDE.

Therapeutic areas

API / Drug Master Files

NANJING CELLNUO BIOPHARMACEUTICAL CO LTD holds 6 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• INSULIN ASPARTActive2026-02-12
• SEMAGLUTIDE INTERMEDIATE P29Active2025-12-19
• SEMAGLUTIDE INTERMEDIATE P29Active2025-12-01
• RETATRUTIDEActive2025-10-24
• TIRZEPATIDEActive2025-03-28
• SEMAGLUTIDE, NON-STERILE DRUG SUBSTANCEActive2024-06-15

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to NANJING CELLNUO BIOPHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.